Data from the MagSense® HER2 Phase 1 study and internal R&D programs have opened new opportunities for Imagion to file for intellectual property and are driving efforts to investigate how analytical methods in Artificial Intelligence (AI) and Machine Learning (ML) might be applied to improve the clinical utility of the MagSense® imaging tests
You might want to look closer at the statements in your linked documents, there are lots of could/should/would etc doesn’t mean that money is going to be rolling in the door anytime soon.
- Forums
- ASX - By Stock
- IBX
- Ann: Notice of Annual General Meeting/Proxy Form
Ann: Notice of Annual General Meeting/Proxy Form, page-9
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
Add IBX (ASX) to my watchlist
|
|||||
Last
2.9¢ |
Change
-0.003(9.38%) |
Mkt cap ! $1.033M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.8¢ | $8.332K | 294.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 85750 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 130296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85750 | 0.028 |
2 | 137000 | 0.027 |
2 | 190274 | 0.020 |
1 | 50000 | 0.015 |
1 | 100000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 130296 | 1 |
0.030 | 100000 | 1 |
0.032 | 80322 | 2 |
0.033 | 20000 | 1 |
0.036 | 9093 | 2 |
Last trade - 15.44pm 12/09/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |